On the Record · Sanofi
Sanofi competitors, on the record
The companies whose own annual reports name Sanofi as a competitor, each with the sentence it appears in and the filing it came from.
Who Sanofi names
Sanofi’s annual reports for 2023 to 2025 describe its competition by kind of business and do not name competing companies.
Who names Sanofi
Companies whose own annual reports name Sanofi as a competitor.
Word for word“Regeneron & Sanofi LIBTAYO U.S., Europe, Asia Pacific & China” 10-K for 2025
Word for word“In other specialties and biosimilar products, we compete with products produced by some of the largest pharmaceutical manufacturers in the world, such as Novartis AG, AstraZeneca AB, Sanofi and GlaxoSmithKline.” 20-F for 2025
Word for word“We also compete against other vaccines, including Sanofi and Novavax’s.” 10-K for 2025
Read from Sanofi’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-02-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.